Erythropoietin induces tumor regression and antitumor immune responses in murine myeloma models (Q35867538)

10 August 2017

Erythropoietin induces tumor regression and antitumor immune responses in murine myeloma models (English)

1 reference

10 August 2017

1 reference

M Mittelman

1

1 reference

10 August 2017

D Neumann

2

1 reference

10 August 2017

A Peled

3

1 reference

10 August 2017

P Kanter

4

1 reference

10 August 2017

N Haran-Ghera

5

1 reference

10 August 2017

language of work or name

English

0 references

publication date

17 April 2001

1 reference

Proceedings of the National Academy of Sciences of the United States of America

10 August 2017

1 reference

10 August 2017

98

1 reference

10 August 2017

9

1 reference

10 August 2017

5181-5186

1 reference

Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=33184

Use of recombinant human erythropoietin outside the setting of uremia

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=33184

Intermediates in degradation of the erythropoietin receptor accumulate and are degraded in lysosomes.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=33184

Disseminated growth of a human multiple myeloma cell line in mice with severe combined immunodeficiency disease.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=33184

Cytokine, cytokine receptors, transduction signals, and oncogenes in human multiple myeloma.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=33184

Increase in the effectiveness of melphalan therapy with progression of MOPC-315 plasmacytoma tumor growth.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=33184

Immunoglobulin-producing tumors and myeloma proteins of mice

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=33184

Synthesis, assembly, and secretion of gamma globulin by mouse myeloma cells. I. Adaptation of the Merwin plasma cell tumor-11 to culture, cloning, and characterization of gamma globulin subunits

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=33184

Cloning and expression of the human erythropoietin gene

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=33184

Animal model of human disease. Multiple myeloma.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=33184

Erythropoietin treatment of anemia associated with multiple myeloma

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=33184

Plasma cell myeloma: biology and treatment

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=33184

Erythropoietin is both a mitogen and a survival factor.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=33184

Specific pathogen-free BALB/cAn mice are refractory to plasmacytoma induction by pristane

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=33184

Multiple myeloma: review of 869 cases

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=33184

Immunoregulation of Murine Myeloma Cell Growth and Differentiation; A Monoclonal Model of B Cell Differentiation1

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=33184

Low doses of radiation induce systemic production of cytokines: possible contribution to leukemogenesis.

27 July 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.081275298

Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.081275298

Treatment of the anemia of progressive renal failure with recombinant human erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.081275298

Clinical results of recombinant erythropoietin in transfusion-dependent patients with refractory multiple myeloma: role of cytokines and monitoring of erythropoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.081275298

Recombinant human erythropoietin in the treatment of multiple myeloma-associated anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.081275298

The selective effect of tunicamycin on the secretion of IgM and IgG produced by the same cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.081275298

IL-6 stimulates osteoclast-like multinucleated cell formation in long term human marrow cultures by inducing IL-1 release

21 January 2018

1 reference

12 December 2020

Recombinant human erythropoietin and the anemia of cancer

1 reference

12 December 2020

Recombinant human erythropoietin in transfusion-dependent anemic patients with multiple myeloma and non-Hodgkin's lymphoma--a randomized multicenter study. The European Study Group of Erythropoietin (Epoetin Beta) Treatment in Multiple Myeloma and N

1 reference

12 December 2020

A tumor-specific Th2 clone initiating tumor rejection via primed CD8+ cytotoxic T-lymphocyte activation in mice

1 reference

12 December 2020

Disseminated growth of murine plasmacytoma: similarities to multiple myeloma

1 reference

12 December 2020

Importance of the B7-2 molecule for low dose melphalan-induced acquisition of tumor-eradicating immunity by mice bearing a large MOPC-315 tumor

1 reference

12 December 2020

Identifiers

DOI

10.1073/PNAS.081275298

1 reference

10 August 2017

0 references

1 reference

10 August 2017

PubMed publication ID

11309490

1 reference